[The association of diabetes and celiac disease: the value of assaying antireticulin antibodies].
The authors studied the specificity and the sensitivity of serum anti-reticulin IgA type antibody determination for the diagnosis of coeliac disease in diabetic patients. They observed a frequency of 11.1% coeliac disease among a group of 54 type I juvenile diabetic patients. The search for serum antireticulin IgA type antibodies appears to be an efficient method for identifying patients with coeliac disease; it has a specificity of 98% and a sensitivity of 95%. This marker appears to be particularly well suited for the identification of asymptomatic forms, and also for surveillance of diet during the course of coeliac disease.
Keddari
M
M
Clinique médicale infantile, CHU Mustapha, Alger, Algérie.
Makhloufi-Djenandar
F
F
Ourabia
A
A
Maiza
E H
EH
Abbadi
M C
MC
Hamza
F
F
Khati
B
B
D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000032:analysis*; D002446:Celiac Disease / Q000209:etiology* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D012155:Reticulin / Q000276:immunology*
D000906:Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D012155:Reticulin
Association diabète et maladie coeliaque: intérêt du dosage des anticorps antiréticuline.